Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury
- 1 September 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 105 (9), 1989-1997
- https://doi.org/10.1097/tp.0000000000003488
Abstract
Background: A major discrepancy between clinical and most experimental settings of liver ischemia-reperfusion injury (IRI) is the allogenicity. Methods: In the current study, we first established a murine model of allogeneic orthotopic liver transplantation (allo-OLT) with extended cold ischemia time (18h). Roles of CD4 T cells in the pathogenesis of ischemia reperfusion injury (IRI) in liver allografts was determined using a depleting anti-CD4 Ab. The clinical relevance of CD4 as a marker of liver IRI was analyzed retrospectively in 55 liver transplant patients. Results: CD4 depletion in both donors and recipients resulted in the most effective protection of liver allografts from IRI, as measured by serum transaminase levels and liver histology. CD4 depletion inhibited IR-induced intra-graft neutrophil/macrophage infiltration and pro-inflammatory gene expressions. Quantitative RT-PCR analysis of human liver biopsies (2h postreperfusion) revealed that post-, rather than pre-, transplant CD4 transcript levels correlated positively with pro-inflammatory gene expression profile. When we divided patients into sub-groups according to intra-graft CD4 levels, the high-CD4 cohort developed a more severe hepatocellular damage than that with low-CD4 levels. Conclusions: CD4 T cells play a key pathogenic role in IRI of allogeneic liver transplants and intra-graft CD4 levels in the early postreperfusion phase may serve as a potential biomarker and therapeutic target to ameliorate liver IRI and improve OLT outcomes.Keywords
This publication has 33 references indexed in Scilit:
- Ischaemia–reperfusion injury in liver transplantation—from bench to bedsideNature Reviews Gastroenterology & Hepatology, 2012
- Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injuryJournal of Hepatology, 2010
- CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injuryJournal of Hepatology, 2009
- Distinct contributions of CD4+T cell subsets in hepatic ischemia/reperfusion injuryAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and plateletsJournal of Hepatology, 2006
- Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantationLiver Transplantation, 2005
- Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodentJournal of Hepatology, 1997
- CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.JCI Insight, 1997
- NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURYTransplantation, 1993
- Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.JCI Insight, 1990